Thermo Fisher Scientific started off the new year with a new member to its family, closing a $1.85 billion acquisition to build out its recombinant protein catalog. The medtech giant announced today ...
Thermo Fisher Scientific made another big move in life sciences at the end of 2021, paying $1.85 billion to buy the recombinant protein maker PeproTech. New Jersey–based PeproTech provides cytokines, ...
Thermo Fisher Scientific Inc. TMO recently announced the completion of its PeproTech buyout on December 30, 2021 for a total cash consideration of around $1.85 billion. The acquisition is set to ...
WALTHAM, Mass., Jan. 5, 2022 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and PeproTech, Inc., a leading developer and manufacturer of recombinant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results